LeMaitre Vascular Ranked #48 of the 100 Best of Massachusetts Businesses
May 27 2011 - 2:00PM
LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral
vascular devices and implants, was ranked as #48 of the 100 Best of
Massachusetts businesses by the Boston Globe. The Globe 100 ranks
the best-performing publicly traded corporations based in
Massachusetts.
"We are honored to receive this recognition," said George W.
LeMaitre, Chairman and CEO. "This is a testament to the hard work
and effort put forth by all employees that produced our solid 2010
results."
About The Boston Globe
The Boston Globe and Boston.com are wholly owned by The New York
Times Company, a leading media company with 2010 revenues of $2.4
billion, which includes The New York Times, the International
Herald Tribune, The Boston Globe, 15 other daily newspapers and
more than 50 Web sites, including NYTimes.com, Boston.com and
About.com. The Company's core purpose is to enhance society by
creating, collecting and distributing high-quality news,
information and entertainment.
About the Globe 100 ranking methodology
The Globe 100 ranks Massachusetts-based public companies based
on financial data from the four quarters ending closest to December
31, 2010, and for corresponding quarters a year earlier. To be
eligible, the company must be traded publicly for the entire 2010
calendar year on the New York Stock Exchange, the Nasdaq or the
American Stock Exchange and report revenue and profit for both 2009
and 2010. Companies are ranked on four criteria: return on average
equity, one-year percentage change in revenue, one-year percentage
change in profit margin and 2010 revenue.
About LeMaitre Vascular
LeMaitre Vascular is a provider of devices and implants for the
treatment of peripheral vascular disease, a condition that affects
more than 20 million people worldwide. We sell vascular devices and
implants to address the needs of our core customer, the vascular
surgeon. Our principal executive offices are located at 63 Second
Avenue, Burlington, Massachusetts 01803. Additional information can
be found at http://www.lemaitre.com.
Forward-Looking Safe Harbor Statement
Certain statements set forth above that are not clearly
historical in nature are forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of
1995. Although LeMaitre Vascular believes that such statements
are based on reasonable assumptions within the bounds of its
knowledge, these forward-looking statements are neither promises
nor guarantees. LeMaitre Vascular's business is subject to
significant risks and uncertainties and there can be no assurance
that its actual results will not differ materially from its
expectations. These risks and uncertainties include, among
others, the risk factors that are discussed in LeMaitre Vascular's
Annual Report on Form 10-K and subsequent filings with the
Securities and Exchange Commission. The forward-looking
statements made in this release are made only as of the date
hereof, and LeMaitre Vascular disclaims any intention or
responsibility for updating predictions or expectations contained
in this release.
CONTACT: LeMaitre Vascular, Inc.
Investor Relations
Aaron Grossman
+1-781-221-2266
http://www.lemaitre.com
http://www.lemaitre.com/investor
LeMaitre Vascular (NASDAQ:LMAT)
Historical Stock Chart
From May 2024 to Jun 2024
LeMaitre Vascular (NASDAQ:LMAT)
Historical Stock Chart
From Jun 2023 to Jun 2024